Trials

  • CERC Trial

    VITAL

    -

    A prospective, single arm clinical investigation evaluating safety and effectiveness/performance of the Microport CardioFlow VitaFlowTM II – Transcatheter Aortic Valve System for the treatment of symptomatic severe aortic stenosis via transcatheter access in increased surgical risk patients

  • CERC Trial

    VITUS Post-Market Registry

    -

    VITUS is a Single-arm, Prospective, Open Label, All Comers, Multicenter Registry of paclitaxel drug-coated balloon angioplasty for the treatment of symptomatic peripheral arterial disease to assess the safety and performance of a paclitaxel drug-coated balloon for the treatment of peripheral...

  • CERC Trial

    ZENITH

    -

    Evaluation of the Safety and Performance of the Zenith LAA Occlusion System and Procedure for the Mechanical Closure of the Left Atrial Appendage (LAA). Left Atrial Appendage (LAA) closure in patients with non-valvular atrial fibrillation and a maximum LAA ostium width and/or deployed occluder...